Sarcoma News

Edward Melian, MD, a radiation oncologist with Loyola Medicine, received the Chicago Radiological Society’s Distinguished Service Award.

Survivors of childhood and adolescent cancer were less likely as adults to have a first live birth than adults who never had cancer, according to results of a population-based study conducted in Sweden and published in Journal of Clinical Oncology.

Luis A. Diaz, MD, has been named head of the division of solid tumor oncology in the department of medicine at Memorial Sloan Kettering Cancer Center.

The FDA issued warning letters to 14 U.S. companies that the agency contends are selling products fraudulently claimed to prevent, diagnose, treat or cure cancer.

Kristy L. Weber, MD, will become the first female president of the American Academy of Orthopedic Surgeons in 2019.

The FDA announced several decisions related to hematology and oncology therapies and devices in the past month.

Men with HIV and nonmelanoma skin cancer faced an elevated risk for Kaposi’s sarcoma, as did men with HIV who lived in locations with high levels of ambient ultraviolet radiation at the time of diagnosis, study data showed.

This year’s American Association for Cancer Research Annual Meeting — titled “Research Propelling Cancer Prevention and Cures” — featured many studies that showed dramatic improvements and promising new therapies across cancers, conducted by the nation’s leading researchers and clinicians.

Patients with cancer who are educated about the benefits of palliative care are more likely to consider incorporating it into their treatment, according to results of a study by the American Psychological Association.

The FDA granted orphan drug designation to ganitumab for the treatment of Ewing sarcoma, according to the drug’s manufacturer.